引入属性关联图以促进医学数据探索:使用流行病学研究数据进行开发和评估
Louis Bellmann1, Alexander Johannes Wiederhold1, Leona Trübe1
1Institute for Applied Medical Informatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
JMIR medical informatics
|July 24, 2024
概括
这项研究引入了一个属性关联图,用于医学界的直观大数据探索. 这种新型工具对缺少的数据具有强大耐用性,并由医生验证,促进了医学知识的发现.
科学领域:
- 医疗信息学 医疗信息学
- 数据可视化 数据可视化
- 统计分析 统计分析
背景情况:
- 可解释和直观的可视化对于从大数据中生成医学知识至关重要.
- 医学中的统计方法需要对高维和缺失数据的稳定性.
- 医生为中心的工具必须整合可解释性,可视化和数据稳定性.
研究的目的:
- 开发一种可访问的工具,用于在没有编程知识的情况下进行视觉数据探索.
- 允许对复杂的参数进行直观调整,并处理缺失的数据.
- 识别和突出与疾病相关的数据模式,并揭示数据集内的属性关系.
主要方法:
- 引入了属性关联图,这是用于视觉数据探索的新型图形结构.
- 利用了强大的统计指标,节点代表属性频率和偏差,边缘代表条件关系.
- 使用Neo4j可视化图表,实现交互式探索,并为用户突出显示关键模式.
主要成果:
- 将属性关联图和仪表板应用于汉堡市健康研究数据集.
- 与心血管疾病的现有文献进行验证的发现,并对差异的潜在解释.
- 在对10名医生进行的用户测试中,系统可用性量表得分为70.5%和81.4%的任务完成率.
结论:
- 属性关联图和仪表板提供直观的视觉数据探索.
- 该工具对高维和缺失的数据具有稳定性,不需要复杂的参数化.
- 通过用户测试和文献比较证实了临床可用性和统计有效性.
相关概念视频
Statistical Methods for Analyzing Epidemiological Data
344
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
344
Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K
Comparing the Survival Analysis of Two or More Groups
170
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
170
Hazard Ratio
108
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
108
Multiple Bar Graph
5.1K
As the name suggests, a multiple bar graph is the same as a bar graph but has multiple bars to depict relationships between different data values. One can include as many parameters as possible. However, each parameter must have the same unit of measurement.
Each bar or column in the multiple bar graph represents a data value. These graphs are used primarily in interrelating two or more sets of data. The categories of different kinds of data are listed along the horizontal or x-axis, whereas...
Each bar or column in the multiple bar graph represents a data value. These graphs are used primarily in interrelating two or more sets of data. The categories of different kinds of data are listed along the horizontal or x-axis, whereas...
5.1K
Kaplan-Meier Approach
119
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
119


